Next Article in Journal
Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer
Next Article in Special Issue
Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial
Previous Article in Journal
Triggers for Palliative Care Referral in Pediatric Oncology
Previous Article in Special Issue
Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck?
 
 
Review

Article Versions Notes

Cancers 2021, 13(6), 1418; https://doi.org/10.3390/cancers13061418
Action Date Notes Link
article xml file uploaded 19 March 2021 16:16 CET Original file -
article xml uploaded. 19 March 2021 16:16 CET Update -
article pdf uploaded. 19 March 2021 16:16 CET Version of Record https://www.mdpi.com/2072-6694/13/6/1418/pdf-vor
article html file updated 19 March 2021 16:18 CET Original file -
article xml file uploaded 23 March 2021 07:31 CET Update -
article xml uploaded. 23 March 2021 07:31 CET Update https://www.mdpi.com/2072-6694/13/6/1418/xml
article pdf uploaded. 23 March 2021 07:31 CET Updated version of record https://www.mdpi.com/2072-6694/13/6/1418/pdf
article html file updated 23 March 2021 07:32 CET Update -
article html file updated 25 July 2022 08:27 CEST Update https://www.mdpi.com/2072-6694/13/6/1418/html
Back to TopTop